EBITDA: Income before interest, taxes, depreciation and amortization.
Organon & Co. (OGN) had EBITDA of $824.00M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.22B |
|
$187.00M |
|
$2.90B |
|
$3.31B |
|
$5.39B |
|
$824.00M |
|
$-399.00M |
|
$425.00M |
|
$425.00M |
|
$187.00M |
|
$187.00M |
|
$187.00M |
|
$187.00M |
|
$824.00M |
|
|
EBITDA |
$824.00M |
259.50M |
|
260.76M |
|
$0.72 |
|
$0.72 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|